drugset / Trial / NCT07502716

Compassionate Use of Ubamatamab

NCT07502716 ↗

Expanded access Available Regeneron Pharmaceuticals

Summary

Provide Compassionate Use of Ubamatamab

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Ubamatamab Monoclonal antibody — —